Plasmonic Ferroelectric Modulator Monolithically Integrated on SiN for 216 GBd Data Transmission
Kohli, M., Chelladurai, D., Messner, A., Horst, Y., Moor, D., Winiger, J., Blatter, T., Buriakova, T., Convertino, C., Eltes, F., Zervas, M., Fedoryshyn, Y., Koch, U., Leuthold, J.
Published in Journal of lightwave technology (15.06.2023)
Published in Journal of lightwave technology (15.06.2023)
Get full text
Journal Article
Single-Mode, Broadband, Near Infrared Light Emission from Metal-Oxide-Semiconductor Tunnel Junctions in Silicon Photonics
Doderer, M., Keller, K., Winiger, J., Baumann, M., Messner, A., Moor, D., Chelladurai, D., Fedoryshyn, Y., Strait, J., Agrawal, A., Parzefall, M., Novotny, L., Lezec, H. J., Leuthold, J., Haffner, C.
Published in 2021 Conference on Lasers and Electro-Optics Europe & European Quantum Electronics Conference (CLEO/Europe-EQEC) (21.06.2021)
Published in 2021 Conference on Lasers and Electro-Optics Europe & European Quantum Electronics Conference (CLEO/Europe-EQEC) (21.06.2021)
Get full text
Conference Proceeding
Determination of the Maximum Tolerated Dose of Panobinostat in Combination with Cytarabine and Mitoxantrone As Salvage Therapy for Relapsed/Refractory Acute Myeloid Leukemia
Schlenk, Richard F., Krauter, Jürgen, Schaich, Markus, Bouscary, Didier, Dombret, Hervé, Winiger, Ivo J., Squier, Margaret, Zahlten, Anita, Wang, Lu, Ottmann, Oliver G.
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
Determination of the Maximum Tolerated Dose of Panobinostat in Combination with a 5-Day Schedule of Azacitidine in High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia: Planned Interim Analysis of a Phase Ib/II Study
Tan, Peter T., Reed, Kate, Walker, Patricia A., Avery, Sharon, Patil, Sushrut S., Grigg, Andrew, Mollee, Peter, Gervasio, Othon L, Winiger, Ivo J., Hönemann, Dirk, Wei, Andrew H, Spencer, Andrew
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
Determination of a Phase II Dose of Panobinostat in Combination with 5-Azacitidine in Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Ottmann, Oliver G., DeAngelo, Daniel J., Garcia-Manero, Guillermo, Lübbert, Michael, Jillella, Anand, Sekeres, Mikkael A., Zahlten, Anita, Squier, Margaret, Acharyya, Suddhasatta, Winiger, Ivo J., Fenaux, Pierre
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
Phase Ib Study of Oral Panobinostat In Combination with 5-Azacitidine (5-aza) In Patients with Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)
Fenaux, Pierre, DeAngelo, Daniel J, Garcia-Manero, Guillermo, Lübbert, Michael, Jillella, Anand P., Sekeres, Mikkael A., Winiger, Ivo J., Squier, Margaret, Li, Xiaodong, Ottmann, Oliver G.
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article
A Phase Ib Dose-Finding Study of Oral Panobinostat In Combination with Cytarabine (ara-C) and Mitoxantrone as Salvage Therapy for Refractory or Relapsed Acute Myeloid Leukemia (AML)
Krauter, Jürgen, Schlenk, Richard F., Schaich, Markus, Bouscary, Didier, Dombret, Hervé, Winiger, Ivo J., Squier, Margaret, Bengoudifa, Bourras-Rezki, Ottmann, Oliver G.
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article
Initial Results of the Phase I/II Panobidara Study of Panobinostat in Combination with Idarubicin and Cytarabine in Patients Aged 65 Years or Older with Newly Diagnosed Acute Myeloblastic Leukaemia (AML)
Ocio, Enrique M, Herrera, Pilar, Olave, Teresa, Brunet, Salut, Oriol, Albert, Martínez-Sánchez, Maria-Pilar, Sanz, Miguel A., Mateos, Marta, Aliseda, Pilar, Winiger, Ivo J., Hardikar, Sushant, Mateos, Maria Victoria, Lopez, Javier, San-Miguel, Jesús F.
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
A phase Ib study of oral panobinostat (LBH589) in combination with cytarabine (ARA-C) and mitoxantrone (MT) as salvage therapy for refractory or relapsed acute myeloid leukemia (AML)
Krauter, J., Ottmann, O. G., Schlenk, R. F., Schaich, M., Bouscary, D., Dombret, H., Lüdicke, F., Weber, H. J., Winiger, I. J.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
A phase Ib study of oral panobinostat (LBH589) administered with 5-azacitidine (5-Aza) in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), or acute myeloid leukemia (AML)
Ottmann, O. G., Fenaux, P., Lübbert, M., DeAngelo, D. J., Garcia-Manero, G., Bhalla, K. N., Sekeres, M. A., Lüdicke, F., Weber, H. J., Winiger, I. J.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article